Forest Laboratories Settlement and Corporate Integrity Agreement
The Department of Justice (DOJ) announced that drug maker Forest Laboratories, Inc. has pleading guilty to resolve criminal…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
PLoS Medicine: Fugh-Berman – Trial Attorney Ghost?
A recent article in PLoS Medicine examined the role ghostwriting played in recent litigation against Wyeth, where more than 14,000…
Home Health Care Planning Improvement Act of 2010
With much of the United States suffering from shortages of primary care physicians, especially in rural regions, nurse…
FDA Bad Ad Program – The End of Trust?
This summer, the Food and Drug Administration (FDA) launched “The Bad Ad Program,” which is designed to educate health care…
Boston Globe a CME Startup Criticizes the Industry
The growing criticism of industry funded continuing medical education (CME) over the past several years has had a number of…
Sunshine in Light of Company Transparency
With the number of drug and devices companies who disclose payments to physicians for a variety of activities (education,…
Archives of Internal Medicine: Soros Funded Study on Disclosure Skirts the…
In October 2009, the International Committee of Medical Journal Editors (ICMJE) recommended a new “Uniform Format for Disclosure…
FDA – DTC Advertising Format Variations Study
The Food and Drug Administration (FDA) announced an opportunity for the public to comment on the Experimental Study of Format…
Pharmaceutical Sponsored Talks Facilitates Two Way Communication on…
Over the past several years, and even more recently, academic medical centers have begun to “tighten restrictions on doctors…
Yale Updates Conflict of Interest Reporting Requirements
Last April, Yale University issued a press release regarding an improved conflict of interest (COI) reporting process in response…